Accel principal investigator shares insight on trial that links routine vaccines with lower Alzheimer’s risk - Alcanza Clinical Research

Create a Profile

I accept digital forms of communication(Required)
This field is hidden when viewing the form
This field is hidden when viewing the form
This field is for validation purposes and should be left unchanged.

Create a Profile

I accept digital forms of communication(Required)
This field is hidden when viewing the form
This field is hidden when viewing the form
This field is for validation purposes and should be left unchanged.

Get In Touch Mobile

I accept digital forms of communication(Required)
This field is for validation purposes and should be left unchanged.

FIND A TRIAL NEAR YOU

No location found for this Zip Code

-- or --

No location found for this Location

FIND A TRIAL NEAR YOU

No location found for this Zip Code

-- or --

No location found for this Location
Back
Date Published: 08/24/2023

Accel principal investigator shares insight on trial that links routine vaccines with lower Alzheimer’s risk

A new study which appeared in the Journal of Alzheimer’s Disease found that several vaccinations commonly given to adults are associated with a reduced risk of developing Alzheimer’s disease.

Dr. Marshall L. Nash, chief principal investigator at Accel Research Sites-NeuroStudies Decatur location and Medical Director for the NeuroStudies subnetwork within Accel Research sites, shared his expertise with Medical News Today on the study and how vaccines relate to Alzheimer’s risk.

Click here to read the full story.

Back

Articles

Ready to be part of healthcare history? Find the right clinical trial for you.

Get In Touch

I accept digital forms of communication(Required)
This field is for validation purposes and should be left unchanged.
Accessibility Adjustment

Color Adjustment

Orientation Adjustment

Font Size

 

Line height